Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VECOPA Pilot Study for Boys with Hodgkin's Lymphoma
NCT00398554Phase 2Completed
- Start
- Jun 2005
- Primary completion
- Oct 2012
- Modality
- Monoclonal Antibodies, Orthosteric Ligands, Targeted Liposomes
- Countries
- 2
01
Overview
A Phase 2 trial of vinblastine, etoposide, cyclophosphamide, vincristine sulfate liposome injection, prednisone in Hodgkin lymphoma (HL). Started Jun 2005; status: completed.
02
Drugs
vinblastineetoposidecyclophosphamidevincristine sulfate liposome injectionprednisone
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00398554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00398554.